Cystic Fibrosis: Implications for Vascular Health and Function (V 1.0)
Research type
Research Study
Full title
Cystic Fibrosis: Implications for Vascular Health and Function (CF-VHF Study)
IRAS ID
374010
Contact name
Frederick Frost
Contact email
Sponsor organisation
Liverpool Heart and Chest Hospital
Duration of Study in the UK
2 years, 3 months, 31 days
Research summary
People with cystic fibrosis (CF) are now living longer largely due to new treatments. As the lifespan of CF patients increases, it is important to understand how ageing affects the health of their blood vessels. Whilst little is currently known about this, some early studies are pointing towards cardiovascular dysfunction in these older CF patients. This study therefore aims to improve the understanding of how ageing in CF patients affects the health and function of their blood vessels (including brain blood vessels).
The study aims to recruit 100 participants: 50 adults diagnosed with CF aged 40 years or older who are receiving these new highly effective CF transmembrane conductance regulator (CFTR) modulators, and 50 healthy adults of a similar age and sex without CF. Participants must not be pregnant or breastfeeding, currently smoke or vape (or have done so within the last 10 years), have significant pre-existing medical conditions, or taking heart-related medications.
Participants will attend a single research visit lasting approximately 3 hours at a research laboratory at the Liverpool Centre of Cardiovascular Science (LCCS) based at Liverpool Heart and Chest Hospital (LHCH). During the visit, participants will complete health and lifestyle questionnaires and undergo several non-invasive assessments, including measurements of height, weight and blood pressure, an electrocardiogram to assess heart activity, ultrasound scans to assess health of blood vessels in the arm, neck, and brain, and a blood sample test. The study has a potential to determine the mechanisms which may be responsible for increased vascular dysfunction which is being reported in some CF patients and will provide important new insights on the health of brain blood vessels in CF patients. Findings of the study could shape the future care and monitoring of this patient group.
The project is being jointly funded by Manchester Metropolitan University and LHCH.
REC name
Wales REC 6
REC reference
26/WA/0219
Date of REC Opinion
6 Aug 2026
REC opinion
Favourable Opinion